|
Prana Biotechnology Limited (ADR) (PRAN) news: Alzheimer's Dementia: Eli …
Seeking Alpha Alzheimer's Dementia is a terrible and costly disease and currently the treatments for it are poor. Solanezumab and PBT2 have both shown that they may help the cognitive decline seen in Alzheimer's Dementia. Solanezumab and PBT2 both need further data … |